10-K Decoder · All companies

Adaptive Biotechnologies Corporation

ADPT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$277M$179M+54.8%
Operating income−$57.1M−$163M+64.9%
Net income−$59.5M−$159M+62.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$83.9M$94.0M−10.7%
Operating income−$500K$10.3M
Net income$2.90M$9.50M−69.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Adaptive's revenue in FY2025?
$277M in FY2025 (Fiscal year ended Dec 31, 2025), +54.8% vs $179M a year earlier, per its 10-K filed Feb 2026.
Was Adaptive profitable in FY2025?
No: net income was −$59.5M and operating income −$57.1M in FY2025.
What was Adaptive's revenue in Q3 2026?
$83.9M (−10.7% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.